Results 191 to 200 of about 82,598 (315)

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox   +46 more
wiley   +1 more source

sublingual tablets

open access: yes
Citation: 'sublingual tablets' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.15237 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Sepiapterin and its major metabolite 6R‐L‐erythro‐5,6,7,8‐tetrahydrobiopterin (BH4) bind to distinct variants of phenylalanine hydroxylase (PAH), which converts excess phenylalanine to tyrosine, thereby stabilizing, enhancing, and prolonging PAH activity.
Lan Gao   +7 more
wiley   +1 more source

Interstitial Cystitis/Bladder Pain Syndrome Patient Phenotyping

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 19-25, January 2026.
ABSTRACT Aims In April of 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on IC/BPS in Winston‐Salem, NC. The goal of this meeting was to establish global consensus regarding diagnostic criteria, phenotyping, treatment outcome assessment, and etiopathology in interstitial cystitis/bladder pain syndrome (IC ...
Dylan T. Wolff   +5 more
wiley   +1 more source

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study

open access: yesAllergy, Volume 81, Issue 1, Page 232-247, January 2026.
The aim of the study is to interrogate immunological mechanisms induced by PQ Grass conventional and extended regimens. A short‐course pre‐seasonal subcutaneous injection of PQ Grass is effective in inducing immune tolerance by generating functional blocking antibodies and modulating T cell compartments.
Janice A. Layhadi   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy